Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Sebban

Showing results (101-110 of 145) with videos related to

Pageof 15
Sort By:
Blood|September 1, 1994
Immunophenotype of adult acute lymphoblastic leukemia, clinical parameters, and outcome: an analysis of a prospective trial including 562 tested patients (LALA87). French Group on Therapy for Adult Acute Lymphoblastic LeukemiaC Boucheix, B David, C Sebban, et al.
Leukemia & Lymphoma|January 1, 1994
Autologous BMT for post-remission therapy in adult ALL: an immunological approach. For The French Group of Therapy of Adult ALLE Racadot, C Sebban, C Boucheix, et al.
Genes, Chromosomes & Cancer|November 1, 1996
dic(4;17)(p11;p11): a new recurrent chromosomal abnormality in chronic B-lymphoid disordersE Callet-Bauchu, R Rimokh, I Tigaud, et al.
European Journal of Haematology. Supplementum|July 13, 2005
How to define intermediate stage in Hodgkin's lymphoma?C Gisselbrecht, N Mounier, M André, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1996
Effect of granulocyte colony-stimulating factor administration in elderly patients with aggressive non-Hodgkin's lymphoma treated with a pirarubicin-combination chemotherapy regimen. Groupe d'Etudes des Lymphomes de l'AdulteA Guerci, P Lederlin, F Reyes, et al.
Leukemia|December 26, 2001
Long-term follow-up of patients with newly diagnosed adult acute lymphoblastic leukemia: a single institution experience of 378 consecutive patients over a 21-year periodX Thomas, C Danaïla, Q H Le, et al.
Neurophysiologie Clinique = Clinical Neurophysiology|December 1, 1991
[The significance of quantified EEG in Alzheimer's disease. Changes induced by piracetam]M Pierlovisi-Lavaivre, B Michel, C Sebban, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1993
Adult acute lymphoblastic leukemia: a multicentric randomized trial testing bone marrow transplantation as postremission therapy. The French Group on Therapy for Adult Acute Lymphoblastic LeukemiaD Fière, E Lepage, C Sebban, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Quality-of-life-adjusted survival analysis of interferon alfa-2b treatment for advanced follicular lymphoma: an aid to clinical decision makingB F Cole, P Solal-Céligny, R D Gelber, et al.
Blood|July 10, 1998
A risk model for thrombocytopenia requiring platelet transfusion after cytotoxic chemotherapyJ Y Blay, A Le Cesne, C Mermet, et al.
Pageof 15

Showing results (101-110 of 145) with videos related to

Sort By:
Pageof 15
Blood|September 1, 1994
Immunophenotype of adult acute lymphoblastic leukemia, clinical parameters, and outcome: an analysis of a prospective trial including 562 tested patients (LALA87). French Group on Therapy for Adult Acute Lymphoblastic LeukemiaC Boucheix, B David, C Sebban, et al.
Leukemia & Lymphoma|January 1, 1994
Autologous BMT for post-remission therapy in adult ALL: an immunological approach. For The French Group of Therapy of Adult ALLE Racadot, C Sebban, C Boucheix, et al.
Genes, Chromosomes & Cancer|November 1, 1996
dic(4;17)(p11;p11): a new recurrent chromosomal abnormality in chronic B-lymphoid disordersE Callet-Bauchu, R Rimokh, I Tigaud, et al.
European Journal of Haematology. Supplementum|July 13, 2005
How to define intermediate stage in Hodgkin's lymphoma?C Gisselbrecht, N Mounier, M André, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1996
Effect of granulocyte colony-stimulating factor administration in elderly patients with aggressive non-Hodgkin's lymphoma treated with a pirarubicin-combination chemotherapy regimen. Groupe d'Etudes des Lymphomes de l'AdulteA Guerci, P Lederlin, F Reyes, et al.
Leukemia|December 26, 2001
Long-term follow-up of patients with newly diagnosed adult acute lymphoblastic leukemia: a single institution experience of 378 consecutive patients over a 21-year periodX Thomas, C Danaïla, Q H Le, et al.
Neurophysiologie Clinique = Clinical Neurophysiology|December 1, 1991
[The significance of quantified EEG in Alzheimer's disease. Changes induced by piracetam]M Pierlovisi-Lavaivre, B Michel, C Sebban, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1993
Adult acute lymphoblastic leukemia: a multicentric randomized trial testing bone marrow transplantation as postremission therapy. The French Group on Therapy for Adult Acute Lymphoblastic LeukemiaD Fière, E Lepage, C Sebban, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Quality-of-life-adjusted survival analysis of interferon alfa-2b treatment for advanced follicular lymphoma: an aid to clinical decision makingB F Cole, P Solal-Céligny, R D Gelber, et al.
Blood|July 10, 1998
A risk model for thrombocytopenia requiring platelet transfusion after cytotoxic chemotherapyJ Y Blay, A Le Cesne, C Mermet, et al.
Pageof 15